{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T10:15:48Z","timestamp":1788257748195,"version":"build-2803163510"},"reference-count":45,"publisher":"Bioscientifica","issue":"4","license":[{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":16,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>In the past years, the discovery of non-oncogene addiction (NOA) has expanded the cancer targets repertoire. In particular, novel strategies are aimed at counteracting the dependency of cancer cells on normal genes that are essential to sustain their stress phenotype. Of the NOA genes, discovered by our group, that are essential for human thyroid cancer cells, we extensively focused on COPZ1, a subunit of coatomer complex I. We previously reported that in in vitro human thyroid cancer models, COPZ1 depletion can induce IFN-I-mediated stimulatory effects, which culminates in immunogenic cell death. To evaluate in vivo the effects of COPZ1 depletion on immunity and inflammation, generation of syngeneic mouse models is needed. Toward this aim, in this work, we studied in vitro the dependency on COPZ1 in murine thyroid cancer cell lines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Cell viability was assessed through crystal violet assay and a commercially available kit. qRT-PCR and western blot were used to evaluate the expression of genes and proteins of interest; commercially available kits were used for monitoring cytokine release and oxidative status.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Analogous to the human counterpart, COPZ1 silencing impaired cell proliferation and induced ER stress in four cell lines. The transcription and secretory IFN-I-related program was activated in two of the four cell lines. In the other two cell lines, we detected an increase in ROS production, lipid peroxidation, and Ca2+ levels.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Activation of inflammatory effects after COPZ1 silencing is cell line-dependent.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1530\/etj-25-0408","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T10:22:43Z","timestamp":1786962163000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-17","source":"Crossref","is-referenced-by-count":0,"title":["COPZ1 depletion induces cell death through different mechanisms in\n                    <i>in vitro<\/i>\n                    murine models of thyroid cancer"],"prefix":"10.1530","volume":"15","author":[{"given":"Tiziana","family":"Di Marco","sequence":"first","affiliation":[{"name":"Integrated Biology of Rare Tumors, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale Dei Tumori 1 , ,","place":["Milan, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debora","family":"Vergaro","sequence":"additional","affiliation":[{"name":"Integrated Biology of Rare Tumors, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale Dei Tumori 1 , ,","place":["Milan, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara","family":"Mazzoni","sequence":"additional","affiliation":[{"name":"Integrated Biology of Rare Tumors, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale Dei Tumori 1 , ,","place":["Milan, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Mazzoleni","sequence":"additional","affiliation":[{"name":"Integrated Biology of Rare Tumors, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale Dei Tumori 1 , ,","place":["Milan, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Muraro","sequence":"additional","affiliation":[{"name":"Integrated Biology of Rare Tumors, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale Dei Tumori 1 , ,","place":["Milan, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Pagliardini","sequence":"additional","affiliation":[{"name":"Integrated Biology of Rare Tumors, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale Dei Tumori 1 , ,","place":["Milan, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2994-0349","authenticated-orcid":true,"given":"Angela","family":"Greco","sequence":"additional","affiliation":[{"name":"Integrated Biology of Rare Tumors, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale Dei Tumori 1 , ,","place":["Milan, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2026,8,17]]},"reference":[{"key":"2026090105413760600_bib1","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1001\/jama.2023.26348","article-title":"Thyroid cancer: a review","volume":"331","author":"Boucai","year":"2024","journal-title":"JAMA"},{"key":"2026090105413760600_bib2","article-title":"Differentiated thyroid cancer after thyroidectomy","volume":"44","author":"Chua","year":"2024","journal-title":"Radiogr Rev Publ Radiol Soc N Am Inc"},{"key":"2026090105413760600_bib3","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqad118","article-title":"Mechanistic insights of thyroid cancer progression","volume":"164","author":"Leandro-Garc\u00eda","year":"2023","journal-title":"Endocrinology"},{"key":"2026090105413760600_bib4","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1093\/annonc\/mdz400","article-title":"Thyroid cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"30","author":"Filetti","year":"2019","journal-title":"Ann Oncol"},{"key":"2026090105413760600_bib5","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3389\/fendo.2020.00082","article-title":"New therapies for advanced thyroid cancer","volume":"11","author":"Laha","year":"2020","journal-title":"Front Endocrinol"},{"key":"2026090105413760600_bib6","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.annonc.2022.04.009","article-title":"ESMO clinical practice guideline update on the use of systemic therapy in advanced thyroid cancer","volume":"33","author":"Filetti","year":"2022","journal-title":"Ann Oncol"},{"key":"2026090105413760600_bib7","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1002\/cncr.34657","article-title":"Efficacy and safety of pembrolizumab monotherapy in patients with advanced thyroid cancer in the phase 2 KEYNOTE-158 study","volume":"129","author":"Oh","year":"2023","journal-title":"Cancer"},{"key":"2026090105413760600_bib8","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1200\/JCO.19.02727","article-title":"PD-1 blockade in Anaplastic thyroid carcinoma","volume":"38","author":"Capdevila","year":"2020","journal-title":"J Clin Oncol"},{"key":"2026090105413760600_bib9","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3390\/biom11020129","article-title":"Targeting non-oncogene addiction for cancer therapy","volume":"11","author":"Chang","year":"2021","journal-title":"Biomolecules"},{"key":"2026090105413760600_bib10","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.cell.2009.02.024","article-title":"Principles of cancer therapy: Oncogene and non-oncogene addiction","volume":"136","author":"Luo","year":"2009","journal-title":"Cell"},{"key":"2026090105413760600_bib11","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.15252\/embr.201643030","article-title":"Drugging the addict: non-oncogene addiction as a target for cancer therapy","volume":"17","author":"Nagel","year":"2016","journal-title":"EMBO Rep"},{"key":"2026090105413760600_bib12","doi-asserted-by":"crossref","first-page":"34629","DOI":"10.18632\/oncotarget.5282","article-title":"Identification of thyroid tumor cell vulnerabilities through a siRNA-based functional screening","volume":"6","author":"Anania","year":"2015","journal-title":"Oncotarget"},{"key":"2026090105413760600_bib13","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1016\/j.febslet.2009.07.032","article-title":"The COPI system: molecular mechanisms and function","volume":"583","author":"Beck","year":"2009","journal-title":"FEBS Lett"},{"key":"2026090105413760600_bib14","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1083\/jcb.200810098","article-title":"Early endosomes and endosomal coatomer are required for autophagy","volume":"185","author":"Razi","year":"2009","journal-title":"J Cell Biol"},{"key":"2026090105413760600_bib15","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1182\/blood.2023022576","article-title":"A new severe congenital neutropenia syndrome associated with autosomal recessive COPZ1 mutations","volume":"145","author":"Borbaran Bravo","year":"2025","journal-title":"Blood"},{"key":"2026090105413760600_bib16","doi-asserted-by":"crossref","first-page":"12449","DOI":"10.1073\/pnas.1103842108","article-title":"Tumor-specific silencing of COPZ2 gene encoding coatomer protein complex subunit \u03b6 2 renders tumor cells dependent on its paralogous gene COPZ1","volume":"108","author":"Shtutman","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026090105413760600_bib17","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.canlet.2017.09.024","article-title":"Targeting COPZ1 non-oncogene addiction counteracts the viability of thyroid tumor cells","volume":"410","author":"Anania","year":"2017","journal-title":"Cancer Lett"},{"key":"2026090105413760600_bib18","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1007\/s12094-022-02869-w","article-title":"BMI1 promotes the proliferation and inhibits autophagy of breast cancer cells by activating COPZ1","volume":"24","author":"Chen","year":"2022","journal-title":"Clin Transl Oncol"},{"key":"2026090105413760600_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagen.2024.130706","article-title":"COPZ1 regulates ferroptosis through NCOA4-mediated ferritinophagy in lung adenocarcinoma","volume":"1868","author":"Wu","year":"2024","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"2026090105413760600_bib20","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1038\/s41388-020-01622-3","article-title":"Loss of COPZ1 induces NCOA4 mediated autophagy and ferroptosis in glioblastoma cell lines","volume":"40","author":"Zhang","year":"2021","journal-title":"Oncogene"},{"key":"2026090105413760600_bib21","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.canlet.2020.02.011","article-title":"COPZ1 depletion in thyroid tumor cells triggers type I IFN response and immunogenic cell death","volume":"476","author":"Di Marco","year":"2020","journal-title":"Cancer Lett"},{"key":"2026090105413760600_bib22","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.18632\/oncotarget.380","article-title":"Thyrocyte-specific inactivation of p53 and Pten results in anaplastic thyroid carcinomas faithfully recapitulating human tumors","volume":"2","author":"Antico Arciuch","year":"2011","journal-title":"Oncotarget"},{"key":"2026090105413760600_bib23","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.1038\/onc.2010.308","article-title":"Cross-talk between PI3K and estrogen in the mouse thyroid predisposes to the development of follicular carcinomas with a higher incidence in females","volume":"29","author":"Antico-Arciuch","year":"2010","journal-title":"Oncogene"},{"key":"2026090105413760600_bib24","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1158\/0008-5472.CAN-06-3524","article-title":"Pten loss in the mouse thyroid causes goiter and follicular adenomas: insights into thyroid function and Cowden disease pathogenesis","volume":"67","author":"Yeager","year":"2007","journal-title":"Cancer Res"},{"key":"2026090105413760600_bib25","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1089\/thy.2013.0483","article-title":"The next generation of orthotopic thyroid cancer models: immunocompetent orthotopic mouse models of BRAF V600E-positive papillary and anaplastic thyroid carcinoma","volume":"24","author":"Vanden Borre","year":"2014","journal-title":"Thyroid"},{"key":"2026090105413760600_bib26","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1038\/onc.2010.136","article-title":"IGFBP7: an oncosuppressor gene in thyroid carcinogenesis","volume":"29","author":"Vizioli","year":"2010","journal-title":"Oncogene"},{"key":"2026090105413760600_bib27","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.canlet.2018.11.010","article-title":"Mitosis perturbation by MASTL depletion impairs the viability of thyroid tumor cells","volume":"442","author":"Cetti","year":"2019","journal-title":"Cancer Lett"},{"key":"2026090105413760600_bib28","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1189\/jlb.0313153","article-title":"Cellular stress response and innate immune signaling: integrating pathways in host defense and inflammation","volume":"94","author":"Muralidharan","year":"2013","journal-title":"J Leukoc Biol"},{"key":"2026090105413760600_bib29","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/imr.13272","article-title":"Type I interferon and cancer","volume":"321","author":"Holicek","year":"2024","journal-title":"Immunol Rev"},{"key":"2026090105413760600_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.590226","article-title":"Iron metabolism in ferroptosis","volume":"8","author":"Chen","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"2026090105413760600_bib31","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ccell.2020.06.001","article-title":"Oxidative stress in cancer","volume":"38","author":"Hayes","year":"2020","journal-title":"Cancer Cell"},{"key":"2026090105413760600_bib32","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3390\/antiox13060697","article-title":"GSH and ferroptosis: side-by-side partners in the fight against tumors","volume":"13","author":"Jiang","year":"2024","journal-title":"Antioxid Basel Switz"},{"key":"2026090105413760600_bib33","article-title":"Paraptosis: a unique cell death mode for targeting cancer","volume":"14","author":"Hanson","year":"2023","journal-title":"Front Pharmacol"},{"key":"2026090105413760600_bib34","doi-asserted-by":"crossref","first-page":"497","DOI":"10.2174\/1568026013394741","article-title":"Oxytosis: a novel form of programmed cell death","volume":"1","author":"Tan","year":"2001","journal-title":"Curr Top Med Chem"},{"key":"2026090105413760600_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252111478","article-title":"Paraptosis-a distinct pathway to cell death","volume":"25","author":"Kunst","year":"2024","journal-title":"Int J Mol Sci"},{"key":"2026090105413760600_bib36","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/sj.cdd.4401465","article-title":"Paraptosis: mediation by MAP kinases and inhibition by AIP-1\/Alix","volume":"11","author":"Sperandio","year":"2004","journal-title":"Cell Death Differ"},{"key":"2026090105413760600_bib37","doi-asserted-by":"crossref","DOI":"10.1091\/mbc.E21-08-0420","article-title":"Depletion of COPI in cancer cells: the role of reactive oxygen species in the induction of lipid accumulation, noncanonical lipophagy and apoptosis","volume":"33","author":"Gasparian","year":"2022","journal-title":"Mol Biol Cell"},{"key":"2026090105413760600_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.ceca.2023.102753","article-title":"Interplay between calcium and endoplasmic reticulum stress","volume":"113","author":"Groenendyk","year":"2023","journal-title":"Cell Calcium"},{"key":"2026090105413760600_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.ceca.2024.102961","article-title":"ER stress as a sentinel mechanism for ER Ca2+ homeostasis","volume":"124","author":"Makio","year":"2024","journal-title":"Cell Calcium"},{"key":"2026090105413760600_bib40","article-title":"COPB1-knockdown induced type I interferon signaling activation inhibits Chlamydia psittaci intracellular proliferation","volume":"16","author":"Li","year":"2025","journal-title":"Front Microbiol"},{"key":"2026090105413760600_bib41","doi-asserted-by":"crossref","first-page":"e20201045","DOI":"10.1084\/jem.20201045","article-title":"A defect in COPI-mediated transport of STING causes immune dysregulation in COPA syndrome","volume":"217","author":"Deng","year":"2020","journal-title":"J Exp Med"},{"key":"2026090105413760600_bib42","doi-asserted-by":"crossref","first-page":"e20200600","DOI":"10.1084\/jem.20200600","article-title":"Mutations in COPA lead to abnormal trafficking of STING to the Golgi and interferon signaling","volume":"217","author":"Lepelley","year":"2020","journal-title":"J Exp Med"},{"key":"2026090105413760600_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.646304","article-title":"STING operation at the ER\/Golgi interface","volume":"12","author":"Taguchi","year":"2021","journal-title":"Front Immunol"},{"key":"2026090105413760600_bib44","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/ng.3279","article-title":"COPA mutations impair ER-Golgi transport and cause hereditary autoimmune-mediated lung disease and arthritis","volume":"47","author":"Watkin","year":"2015","journal-title":"Nat Genet"},{"key":"2026090105413760600_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217786","article-title":"Targeting of COP\u2160 elicits CD8+ T cell-mediated anti-tumor immunity and suppresses growth of intrahepatic cholangiocarcinoma","volume":"626","author":"Chen","year":"2025","journal-title":"Cancer Lett"}],"container-title":["European Thyroid Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.bioscientifica.com\/etj\/article-pdf\/doi\/10.1530\/ETJ-25-0408\/523701\/etj-25-0408.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/etj\/article-pdf\/doi\/10.1530\/ETJ-25-0408\/523701\/etj-25-0408.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T09:41:47Z","timestamp":1788255707000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/etj\/article\/15\/4\/ETJ250408\/78011\/COPZ1-depletion-induces-cell-death-through"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,1]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8,1]]}},"URL":"https:\/\/doi.org\/10.1530\/etj-25-0408","relation":{},"ISSN":["2235-0640","2235-0802"],"issn-type":[{"value":"2235-0640","type":"print"},{"value":"2235-0802","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,1]]},"article-number":"ETJ250408"}}